Completed NA INTERVENTIONAL 2-arm NCT00729755

Creatine Augmentation Treatment in Major Depressive Disorder Subjects

Efficacy and Safety of Augmentation of Creatine for the Patients With Major Depressive Disorder

Sponsor: Ewha Womans University

Interventions Creatine monohydrate Placebo

Updated 7 times since 2017 Last updated: Jul 3, 2017 Started: Aug 31, 2008 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00729755, this NA trial focuses on Major Depressive Disorder and remains completed. Sponsored by Ewha Womans University, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Aug 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ewha Womans University

Data source: Ewha Womans University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bucheon-si, South Korea
• Seoul, South Korea